ArticleFrontiers in cell and developmental biology2026

Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer.

Homood M As Sobeai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.